Labandero, Venancio B.
HRN: 12-13-69 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/11/2024
CEFTRIAXONE 1G (VIAL)
04/11/2024
04/17/2024
IV
2g
OD
Perforated PUD
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes